A prospective, multicenter study of hepatitis B birth-dose vaccine with or without hepatitis B immunoglobulin in preventing mother-to-child transmission of hepatitis B virus in Ethiopia
Birth-dose HBV vaccine with or without HBIg significantly reduced the risk of MTCT of HBV in Ethiopia. Improved coverage of birth-dose HBV vaccine should be an urgent priority.
Authors
- Nega Berhe (ORCID: https://orcid.org/0000-0001-6959-989X)
- Mahlet Osman
- Andargachew Mulu (ORCID: https://orcid.org/0000-0003-2862-0175)
- Adane Mihret (ORCID: https://orcid.org/0000-0003-3183-4772)
- Dawit Hailu Alemayehu (ORCID: https://orcid.org/0000-0002-4118-8260)
- Asgeir Johannessen (ORCID: https://orcid.org/0000-0001-5966-7166)
- Tilahun Teklehaymanot (ORCID: https://orcid.org/0000-0002-0627-5545)
- Mebrihit Arefaine
Institutions
- Oslo University Hospital (NO)
- Armauer Hansen Research Institute (ET)
- Addis Ababa University (ET)
Publication Details
- Journal
- Vaccine
- Published
- 2024-10-19
- DOI
- https://doi.org/10.1016/j.vaccine.2024.126461
- Citations
- 5
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.93
Funders
- Armauer Hansen Research Institute
- Addis Ababa University
- Sykehuset i Vestfold